Mycenax participates in the BIO International Convention, the world's largest biotechnology industry exhibition, and actively expands its business.
The BIO International Convention is the world's largest annual biotech event, held in major cities in the United States. This year's convention was held in Philadelphia, USA from June 3rd to 6th. Mycenax participated in an exhibition group consisting of Taiwanese officials and industry and exhibited at the Taiwan Pavilion to introduce its one-stop CDMO service for biopharmaceutical research and development.
Since its establishment, Mycenax has developed its own biosimilar products and accumulated a considerable number of experience in commissioned services. It has rich experience in product development, production, and quality management, and can provide a series of services with fast service, high quality, and reliability. From research and development strategies and execution plans to providing bio-medical development platforms, we provide listed products that meet customer requirements for regulatory and quality requirements.
Through the docking negotiation of this exhibition, we will continue to contact many potential customers, show our accumulated experience and advantages, and create business opportunities worldwide.